Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS Platform. | J Chem Inf Model | 2024 | 38134123 | PubTator, text mining | PubMed |
| Phytochemical profiling, in vitro biological activities, and in silico (molecular docking and absorption, distribution, metabolism, excretion, toxicity) studies of Polygonum cognatum Meissn. | J Sep Sci | 2024 | 38066395 | PubTator, text mining | PubMed |
| NAK-associated protein 1/NAP1 activates TBK1 to ensure accurate mitosis and cytokinesis. | J Cell Biol | 2024 | 38059900 | PubTator, text mining | PubMed |
| Design, synthesis, and biological activity evaluation of new tankyrase-2 directed inhibitors. | Chem Biol Drug Des | 2024 | 37814809 | PubTator, text mining | PubMed |
| Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37741944 | PubTator, text mining | PubMed |
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| Nod-like receptors in inflammatory arthritis. | Biomed J | 2024 | 37598797 | PubTator, text mining | PubMed |
| Molecular docking, pharmacokinetic prediction and molecular dynamics simulations of tankyrase inhibitor compounds with the protein glucokinase, induced in the development of diabetes. | J Biomol Struct Dyn | 2024 | 37199320 | PubTator, text mining | PubMed |
| Targeting cancer stem cell plasticity in triple-negative breast cancer. | Explor Target Antitumor Ther | 2023 | 38213533 | PubTator, text mining | PubMed |
| Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy. | Cells | 2023 | 38201233 | PubTator, text mining | PubMed |
| Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. | Viruses | 2023 | 38140597 | PubTator, text mining | PubMed |
| Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization. | Front Oncol | 2023 | 38111536 | PubTator, text mining | PubMed |
| Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer. | J Hematol Oncol | 2023 | 38110976 | PubTator, text mining | PubMed |
| Research progress on the mechanism of glycolysis in ovarian cancer. | Front Immunol | 2023 | 38090580 | PubTator, text mining | PubMed |
| Harnessing bioengineered myeloid progenitors for precision immunotherapies. | NPJ Regen Med | 2023 | 38086850 | PubTator, text mining | PubMed |
| Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer. | Sci Rep | 2023 | 38071230 | PubTator, text mining | PubMed |
| Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review. | Int J Mol Sci | 2023 | 38069314 | PubTator, text mining | PubMed |
| TBM Hunter: Identify and Score Canonical, Extended, and Unconventional Tankyrase-Binding Motifs in Any Protein. | Int J Mol Sci | 2023 | 38069287 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| Epistasis regulates genetic control of cardiac hypertrophy. | Res Sq | 2023 | 38045390 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=7